{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:29:55Z","timestamp":1753882195354,"version":"3.41.2"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"HHS | National Institutes of Health","award":["AI153758, AI107784"],"award-info":[{"award-number":["AI153758, AI107784"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2023,9,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Boosting herpes simplex virus (HSV)-specific immunity in the genital tissues of HSV-positive individuals to increase control of HSV-2 recurrent disease and virus shedding is an important goal of therapeutic immunization and would impact HSV-2 transmission. Experimental therapeutic HSV-2 vaccines delivered by a parenteral route have resulted in decreased recurrent disease in experimental animals. We used a guinea pig model of HSV-2 infection to test if HSV-specific antibody and cell-mediated responses in the vaginal mucosa would be more effectively increased by intravaginal (Ivag) therapeutic immunization compared to parenteral immunization. Therapeutic immunization with HSV glycoproteins and CpG adjuvant increased glycoprotein-specific IgG titers in vaginal secretions and serum to comparable levels in Ivag- and intramuscular (IM)-immunized animals. However, the mean numbers of HSV glycoprotein-specific antibody secreting cells (ASCs) and IFN-\u03b3 SCs were greater in Ivag-immunized animals demonstrating superior boosting of immunity in the vaginal mucosa compared to parenteral immunization. Therapeutic Ivag immunization also resulted in a significant decrease in the cumulative mean lesion days compared to IM immunization. There was no difference in the incidence or magnitude of HSV-2 shedding in either therapeutic immunization group compared to control-treated animals. Collectively, these data demonstrated that Ivag therapeutic immunization was superior compared to parenteral immunization to boost HSV-2 antigen-specific ASC and IFN-\u03b3 SC responses in the vagina and control recurrent HSV-2 disease. These results suggest that novel antigen delivery methods providing controlled release of optimized antigen\/adjuvant combinations in the vaginal mucosa would be an effective approach for therapeutic HSV vaccines.<\/jats:p>\n          <jats:sec>\n            <jats:title>IMPORTANCE<\/jats:title>\n            <jats:p>HSV-2 replicates in skin cells before it infects sensory nerve cells where it establishes a lifelong but mostly silent infection. HSV-2 occasionally reactivates, producing new virus which is released back at the skin surface and may be transmitted to new individuals. Some HSV-specific immune cells reside at the skin site of the HSV-2 infection that can quickly activate and clear new virus. Immunizing people already infected with HSV-2 to boost their skin-resident immune cells and rapidly control the new HSV-2 infection is logical, but we do not know the best way to administer the vaccine to achieve this goal. In this study, a therapeutic vaccine given intravaginally resulted in significantly better protection against HSV-2 disease than immunization with the same vaccine by a conventional route. Immunization by the intravaginal route resulted in greater stimulation of vaginal-resident, virus-specific cells that produced antibody and produced immune molecules to rapidly clear virus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/jvi.00669-23","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T13:04:14Z","timestamp":1693573454000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease"],"prefix":"10.1128","volume":"97","author":[{"given":"Nigel","family":"Bourne","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Department of Pediatrics, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Sealy Institute for Vaccine Sciences, University of Texas Medical Branch , Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste A.","family":"Keith","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch , Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch , Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Pyles","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Department of Pediatrics, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Sealy Institute for Vaccine Sciences, University of Texas Medical Branch , Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Basic and Translational Sciences, University of Pennsylvania , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-4552","authenticated-orcid":false,"given":"Gregg N.","family":"Milligan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Department of Pediatrics, University of Texas Medical Branch , Galveston, Texas, USA"},{"name":"Sealy Institute for Vaccine Sciences, University of Texas Medical Branch , Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140765"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1332802"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711123172002"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102143240704"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/314502"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/496979"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001875"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30405-X"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.061606.095540"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-198501000-00007"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2004.06.004"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/591913"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.12.6093"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01237-12"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2010.06.155"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114652"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061792"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12110"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4529"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix004"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy415"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(90)90029-6"},{"key":"e_1_3_3_24_2","first-page":"121","article-title":"Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization","volume":"70","author":"Thapar MA","year":"1990","unstructured":"Thapar MA , Parr EL , Parr MB . 1990. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70:121\u2013125.","journal-title":"Immunology"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08511"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.077"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02309-18"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11522"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0129-1"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.17.11537-11540.2005"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/498247"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.059"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02013-05"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2008.81"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142088"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1758"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.47"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012861108"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1285-1"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.18.9232-9241.2002"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.5934-5944.1999"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-82-4-845"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082039"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007095"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006614107"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01721-18"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.01.005"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1086\/374002"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24154"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.01.018"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0166-3542(98)00055-2"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-484-5_24"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00669-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00669-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:23:20Z","timestamp":1695907400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.00669-23"}},"subtitle":[],"editor":[{"given":"Anna Ruth","family":"Cliffe","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,28]]}},"alternative-id":["10.1128\/jvi.00669-23"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00669-23","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"type":"print","value":"0022-538X"},{"type":"electronic","value":"1098-5514"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"2023-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00669-23"}}